Patient satisfaction from two studies of collaborative doctor – pharmacist prescribing in <scp>A</scp>ustralia

Hale, Andrew; Coombes, Ian; Stokes, Julie; Aitken, Stuart A.; Clark, Fiona; Nissen, Lisa

doi:10.1111/hex.12329

Cited by 41 publications

(47 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pharmacist prescribing in Australia has to date, lagged behind other Anglophone countries. Currently however, Health Workforce Australia is developing a national pathway for prescribing by health professionals other than doctors [Hale et al 2015]. A number of Western-European and Anglophone countries have introduced nurse prescribing, including countries such as Australia, Canada, Sweden, Finland, Ireland, Netherlands, New Zealand and Spain.…”

Section: Nonmedical Prescribing Internationallymentioning

confidence: 99%

Nonmedical prescribing: where are we now?

Cope¹,

Abuzour

Tully

2016

Therapeutic Advances in Drug Safety

136

131

View full text Add to dashboard Cite

Nonmedical prescribing has been allowed in the United Kingdom (UK) since 1992. Its development over the past 24 years has been marked by changes in legislation, enabling the progression towards independent prescribing for nurses, pharmacists and a range of allied health professionals. Although the UK has led the way regarding the introduction of nonmedical prescribing, it is now seen in a number of other Western-European and Anglophone countries although the models of application vary widely between countries. The programme of study to become a nonmedical prescriber (NMP) within the UK is rigorous, and involves a combination of taught curricula and practice-based learning. Prescribing is a complex skill that is high risk and error prone, with many influencing factors. Literature reports regarding the impact of nonmedical prescribing are sparse, with the majority of prescribing research tending to focus instead on prescribing by doctors. The impact of nonmedical prescribing however is important to evaluate, and can be carried out from several perspectives. This review takes a brief look back at the history of nonmedical prescribing, and compares this with the international situation. It also describes the processes required to qualify as a NMP in the UK, potential influences on nonmedical prescribing and the impact of nonmedical prescribing on patient opinions and outcomes and the opinions of doctors and other healthcare professionals.

show abstract

Section: Nonmedical Prescribing Internationallymentioning

confidence: 99%

Nonmedical prescribing: where are we now?

Cope¹,

Abuzour

Tully

2016

Therapeutic Advances in Drug Safety

136

131

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

“…Australian researchers have explored stakeholders’ perceptions and outcomes of PP, and education and training requirements for expanding pharmacists’ scope of practice . Pharmacists and patients indicated support for supplementary rather than IP roles, due to concerns about PP competence . The positive effect of supplementary PP and the competence of pharmacist prescribers have been verified in clinical trials and assisted training to support this expanded scope has been identified .…”

Section: Introductionmentioning

confidence: 99%

Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences

Zhou

Desborough

Parkinson

et al. 2019

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

Objectives Non‐medical prescribers, including pharmacists, have been found to achieve comparable clinical outcomes with doctors for certain health conditions. Legislation supporting pharmacist prescribing (PP) has been implemented in the United Kingdom (UK), Canada and New Zealand (NZ); however, to date, Australian pharmacists have not been extended prescribing rights. The purpose of this review was to describe the barriers to PP found in the literature from the UK, Canada, NZ and Australia, and examine the implications of these for the development of PP in Australia. Methods We conducted a scoping review, which included peer‐reviewed and grey literature, and consultation with stakeholders. Sources – Scopus, PubMed and CINAHL; Google Scholar, OpenGrey and organisational websites from January 2003 to March 2018 in the UK, Canada, NZ and Australia. Inclusion criteria – articles published in English, related to implementation of PP and articulated barriers to PP. Key findings Of 863 unique records, 120 were reviewed and 64 articles were eligible for inclusion. Three key themes emerged: (1) Socio‐political context, (2) Resourcing issues and (3) Prescriber competence. The most common barriers were inadequate training regarding diagnostic knowledge and skills, inadequate support from authorities and stakeholders, and insufficient funding/reimbursement. Conclusions If implementation of PP is to occur, attention needs to be focused on addressing identified barriers to PP implementation, including fostering a favourable socio‐political context and prescriber competence. As such, a concerted effort is required to develop clear policy pathways, including targeted training courses, raising stakeholder recognition of PP and identifying specific funding, infrastructure and resourcing needs to ensure the smooth integration of pharmacist prescribers within interprofessional clinical teams.

show abstract

“…59,60 Australia has developed a governance policy for nonmedical prescribers in Australia, that is, the Health Workforce Australia (HWA) Health Professionals Prescribing Pathway (HPPP) Project; however implementation of this policy is still under consultation. 61,62 NZ does not have any systems in place yet to enable the development of an NMP implementation policy. A viable solution for NZ would involve the development and implementation of a national policy for NMP in NZ.…”

Section: Prescribing Models and Prescribing Settings Of Nonmedical Prmentioning

confidence: 99%

Non-medical prescribing in New Zealand: an overview of prescribing rights, service delivery models and training

Raghunandan

Tordoff

Smith

2017

Therapeutic Advances in Drug Safety

View full text Add to dashboard Cite

Aim:In this paper, we aim to provide an updated source of information for nonmedical prescribing (NMP) in New Zealand (NZ). Methods: A variety of NZ sources were used to collect data: legislation, policy documents and information from professional and regulatory organizations, and education providers. Results: In NZ, the legal categories for prescribers include authorized, designated, and delegated prescribers. Authorized prescribers include dentists, midwives, nurse practitioners, and optometrist prescribers. Designated prescribers include pharmacist prescribers, registered nurse prescribers, and dietitian prescribers. There are no delegated prescribers in NZ at this time. There is variation in the regulation, educational programmes and prescribing competencies used by the different prescribing health professionals involved in NMP in NZ. Conclusion: This update collates relevant information relating to NMP in NZ into one consolidated document and provides policy makers with a current overview of prescribing rights, service delivery models, training requirements, and prescribing competencies used for NMP in NZ. As NMP in NZ continues to expand and evolve, this paper will form a baseline for future NMP research in NZ. NZ needs to develop overarching NMP policy to enable consistency in the various aspects of NMP, thereby delivering a safe and sustainable NMP service in NZ.

show abstract

Patient satisfaction from two studies of collaborative doctor – pharmacist prescribing in Australia

Abstract: Background Pharmacist prescribing has been introduced in several countries and is a possible future role for pharmacy in Australia.

Cited by 41 publications

References 11 publications

Nonmedical prescribing: where are we now?

Nonmedical prescribing: where are we now?

Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences

Non-medical prescribing in New Zealand: an overview of prescribing rights, service delivery models and training

Contact Info

Product

Resources

About